Evidence map›Paper›PMID 36405266›Full record

ArticleWorld journal of clinical cases2022

Development and validation of a risk assessment model for prediabetes in China national diabetes survey.

Li-Ping Yu, Fen Dong, Yong-Ze Li, Wen-Ying Yang, Si-Nan Wu, Zhong-Yan Shan, Wei-Ping Teng, Bo Zhang

Abstract read
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li-Ping YuDepartment of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China.
Fen DongInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Yong-Ze LiDepartment of Endocrinology and Metabolism, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
Wen-Ying YangDepartment of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China.
Si-Nan WuInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Zhong-Yan ShanDepartment of Endocrinology and Metabolism, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
Wei-Ping TengDepartment of Endocrinology and Metabolism, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
Bo ZhangDepartment of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China. prediabetes@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrediabetes risk assessment models derived from large sample sizes are scarce.

aimTo establish a robust assessment model for prediabetes and to validate the model in different populations.

methodsThe China National Diabetes and Metabolic Disorders Study (CNDMDS) collected information from 47325 participants aged at least 20 years across China from 2007 to 2008. The Thyroid Disorders, Iodine Status and Diabetes Epidemiological Survey (TIDE) study collected data from 66108 participants aged at least 18 years across China from 2015 to 2017. A logistic model with stepwise selection was performed to identify significant risk factors for prediabetes and was internally validated by bootstrapping in the CNDMDS. External validations were performed in diverse populations, including populations of Hispanic (Mexican American, other Hispanic) and non-Hispanic (White, Black and Asian) participants in the National Health and Nutrition Examination Survey (NHANES) in the United States and 66108 participants in the TIDE study in China. C statistics and calibration plots were adopted to evaluate the model's discrimination and calibration performance.

resultsA set of easily measured indicators (age, education, family history of diabetes, waist circumference, body mass index, and systolic blood pressure) were selected as significant risk factors. A risk assessment model was established for prediabetes with a C statistic of 0.6998 (95%CI: 0.6933 to 0.7063) and a calibration slope of 1.0002. When externally validated in the NHANES and TIDE studies, the model showed increased C statistics in Mexican American, other Hispanic, Non-Hispanic Black, Asian and Chinese populations but a slightly decreased C statistic in non-Hispanic White individuals. Applying the risk assessment model to the TIDE population, we obtained a C statistic of 0.7308 (95%CI: 0.7260 to 0.7357) and a calibration slope of 1.1137. A risk score was derived to assess prediabetes. Individuals with scores ≥ 7 points were at high risk of prediabetes, with a sensitivity of 60.19% and specificity of 67.59%.

conclusionAn easy-to-use assessment model for prediabetes was established and was internally and externally validated in different populations. The model had a satisfactory performance and could screen individuals with a high risk of prediabetes.

Indexed as

HyperglycemiaPrediabetesRisk assessment modelRisk scores

Identifiers

PMID36405266
PMCPMC9669875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.